These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7605956)

  • 1. [The value of in-vivo 31-phosphorus spectroscopy in the diagnosis of generalized muscular diseases. The clinical results and the differential diagnostic aspects].
    Vogl TJ; Söllner O; Dadashi AR; Reimers CD; Banzer D; Felix R
    Rofo; 1995 Jun; 162(6):455-63. PubMed ID: 7605956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The 31-phosphorus spectroscopy of space-occupying lesions of the salivary glands. The clinical results and differential diagnosis].
    Vogl TJ; Dadashi A; Jassoy A; Becker C; Reimann V; Lissner J
    Rofo; 1993 Jan; 158(1):31-8. PubMed ID: 8425072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
    Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
    Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
    Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
    Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 31-P mr spectroscopy of a leg lymphangiosarcoma.
    Kiricuta IC; Bluemm RG; Krawzak HW; Rühl J; Beyer HK
    Lymphology; 1994 Jun; 27(2):82-9. PubMed ID: 8078364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy.
    Dewhirst MW; Poulson JM; Yu D; Sanders L; Lora-Michiels M; Vujaskovic Z; Jones EL; Samulski TV; Powers BE; Brizel DM; Prosnitz LR; Charles HC
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):480-91. PubMed ID: 15667971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current status of magnetic resonance spectroscopy--basic and clinical aspects.
    Chan L
    West J Med; 1985 Dec; 143(6):773-81. PubMed ID: 3911590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [31P-MR spectroscopy of the human liver--the spectral indications of lymphoma infiltration].
    Heindel W; du Mesnil de Rochemont R; Kugel H; Ernst S; Tesch H; Diehl V; Lackner K
    Rofo; 1997 Jul; 167(1):62-70. PubMed ID: 9289045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear magnetic resonance (NMR) in clinical diagnosis.
    Brady TJ; Koutcher JA
    Adv Intern Med; 1986; 31():419-46. PubMed ID: 3511626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vivo 31-phosphorus magnetic resonance spectroscopy of liver diseases].
    Brinkmann G; Melchert U; Förger K; Wunsch-Binder F; Heidemann H; Engemann R
    Rofo; 1990 Aug; 153(2):204-8. PubMed ID: 2168078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nuclear magnetic resonance tomography in the diagnosis of muscular diseases].
    Kaiser WA; Schalke BC; Rohkamm R
    Rofo; 1986 Aug; 145(2):199-205. PubMed ID: 3018859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine X-linked muscular dystrophy studied with in vivo phosphorus magnetic resonance spectroscopy.
    McCully K; Giger U; Argov Z; Valentine B; Cooper B; Chance B; Bank W
    Muscle Nerve; 1991 Nov; 14(11):1091-8. PubMed ID: 1745283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamic 31-phosphorus magnetic resonance spectroscopy of the m. quadriceps: therapy-induced changes in arterial occlusive disease].
    Schunk K; Romaneehsen B; Dahm M; Dietz U; Kersjes W; Schadmand-Fischer S; Düber C; Thelen M
    Rofo; 1997 Aug; 167(2):139-46. PubMed ID: 9333354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study.
    Schneider-Gold C; Beer M; Köstler H; Buchner S; Sandstede J; Hahn D; Toyka KV
    Muscle Nerve; 2004 Nov; 30(5):636-44. PubMed ID: 15452841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [31P NMR spectroscopy of muscular diseases: correlation with MR imaging].
    Kaiser WA; Hartl W; Sturm H; Schalke BC; Zeitler E
    Rofo; 1987 Feb; 146(2):137-44. PubMed ID: 3029825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [31P-mr spectroscopy of peripheral skeletal musculature under load: demonstration of normal energy metabolites compared with metabolic muscle diseases].
    Block W; Träber F; Kuhl CK; Keller E; Lamerichs R; Karitzky J; Rink H; Schild HH
    Rofo; 1998 Mar; 168(3):250-7. PubMed ID: 9551111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle metabolism in Duchenne muscular dystrophy assessed by in vivo proton magnetic resonance spectroscopy.
    Hsieh TJ; Jaw TS; Chuang HY; Jong YJ; Liu GC; Li CW
    J Comput Assist Tomogr; 2009; 33(1):150-4. PubMed ID: 19188804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo 31-phosphorus MR spectroscopy of the calf musculature in arterial occlusive diseases].
    Melchert UH; Brinkmann G; Förger K; Gleim M; Wunsch-Binder F; Maier C; Zick G
    Rofo; 1992 Apr; 156(4):346-52. PubMed ID: 1571516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.
    Arnold DL; Taylor DJ; Radda GK
    Ann Neurol; 1985 Aug; 18(2):189-96. PubMed ID: 4037759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [31P-MR spectroscopy of liver diseases with reference to variable pulse recovery times].
    Brinkmann G; Melchert UH; Lalk G; Heller M
    Rofo; 1993 Nov; 159(5):412-8. PubMed ID: 8219133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.